» Articles » PMID: 27465657

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy

Overview
Journal Am J Clin Oncol
Specialty Oncology
Date 2016 Jul 29
PMID 27465657
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The rate of contralateral prophylactic mastectomy (CPM) has risen sharply in the past decade. The current study was designed to examine social network, surgeon, and media influence on patients' CPM decision-making, examining not only who influenced the decision, and to what extent, but also the type of influence exerted.

Methods: Patients (N=113) who underwent CPM at 4 Indiana University-affiliated hospitals between 2008 and 2012 completed structured telephone interviews in 2013. Questions addressed the involvement and influence of the social network (family, friends, and nonsurgeon health professionals), surgeon, and media on the CPM decision.

Results: Spouses, children, family, friends, and health professionals were reported as exerting a meaningful degree of influence on patients' decisions, largely in ways that were positive or neutral toward CPM. Most surgeons were regarded as providing options rather than encouraging or discouraging CPM. Media influence was present, but limited.

Conclusions: Patients who choose CPM do so with influence and support from members of their social networks. Reversing the increasing choice of CPM will require educating these influential others, which can be accomplished by encouraging patients to include them in clinical consultations, and by providing patients with educational materials that can be shared with their social networks. Surgeons need to be perceived as having an opinion, specifically that CPM should be reserved for those patients for whom it is medically indicated.

Citing Articles

Contralateral Prophylactic Mastectomy Decision-Making: The Partners' Perspective.

Nash A, Bloom D, Chapman B, Wheeler S, McGuire K, Lee C Ann Surg Oncol. 2023; 30(10):6268-6274.

PMID: 37573282 DOI: 10.1245/s10434-023-14022-0.


A Response and Discussion with Respect to Gulcelik's Study in Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment.

Rivera A, Gascon D Breast Care (Basel). 2023; 17(6):586-587.

PMID: 36590150 PMC: 9801399. DOI: 10.1159/000524546.


Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets.

Nelson J, Rubenstein R, Haglich K, Chu J, Yin S, Stern C JAMA Surg. 2022; 157(8):702-711.

PMID: 35675047 PMC: 9178497. DOI: 10.1001/jamasurg.2022.2065.


Genetic Counseling, Screening and Risk-Reducing Surgery in Patients with Primary Breast Cancer and Germline BRCA Mutations: Unmet Needs in Low- and Middle-Income Countries.

Moukadem H, Al Masry A, Atwani R, Kreidieh F, Khalil L, Saroufim R Eur J Breast Health. 2022; 18(1):16-20.

PMID: 35059587 PMC: 8734520. DOI: 10.4274/ejbh.galenos.2021.2021-5-1.


Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons.

Greenup R, Rushing C, Fish L, Lane W, Peppercorn J, Bellavance E Ann Surg Oncol. 2019; 26(10):3141-3151.

PMID: 31342390 PMC: 7418033. DOI: 10.1245/s10434-019-07594-3.


References
1.
Tuttle T, Jarosek S, Habermann E, Arrington A, Abraham A, Morris T . Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009; 27(9):1362-7. DOI: 10.1200/JCO.2008.20.1681. View

2.
Yao K, Stewart A, Winchester D, Winchester D . Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010; 17(10):2554-62. DOI: 10.1245/s10434-010-1091-3. View

3.
Yakoub D, Avisar E, Koru-Sengul T, Miao F, Tannenbaum S, Byrne M . Factors associated with contralateral preventive mastectomy. Breast Cancer (Dove Med Press). 2015; 7:1-8. PMC: 4293214. DOI: 10.2147/BCTT.S72737. View

4.
Parker P, Peterson S, Bedrosian I, Crosby M, Shen Y, Black D . Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer. Ann Surg. 2015; 263(1):178-83. PMC: 4973510. DOI: 10.1097/SLA.0000000000001216. View

5.
Grimmer L, Liederbach E, Velasco J, Pesce C, Wang C, Yao K . Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base. J Am Coll Surg. 2015; 221(1):187-96. DOI: 10.1016/j.jamcollsurg.2015.03.033. View